awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30802505-E3E8904C-5890-46AA-9095-201864DF392D
Q30802505-E3E8904C-5890-46AA-9095-201864DF392D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30802505-E3E8904C-5890-46AA-9095-201864DF392D
Pomalidomide for the treatment of relapsed-refractory multiple myeloma: a review of biological and clinical data.
P2860
Q30802505-E3E8904C-5890-46AA-9095-201864DF392D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30802505-E3E8904C-5890-46AA-9095-201864DF392D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
76aacdee5a04be40d710a93cc6159b7c7b60a767
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.